The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Workforce
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Mitigating Preeclampsia Risk May Reduce Preterm Birth, Cesarean Delivery

Mitigating Preeclampsia Risk May Reduce Preterm Birth, Cesarean Delivery

December 14, 2020 • By Mary Beth Nierengarten

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Interventions targeted at mitigating the risk of preeclampsia may reduce preterm birth and cesarean delivery in women with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and psoriasis. That’s one key finding of a retrospective study published in Arthritis Care & Research.1 The study set out to quantify the mediated effects of autoimmune conditions on adverse pregnancy outcomes.

You Might Also Like
  • Lupus Flares Pose Greatest Risk for Adverse Pregnancy Outcomes in Women with SLE
  • A More Complicated Pregnancy: Inflammatory Arthritis Increases the Risk for Adverse Outcomes
  • Juvenile-Onset Arthritis Bodes Worse Pregnancy Outcomes
Explore This Issue
December 2020
Also By This Author
  • Challenges Rheumatologists Will Face in 2017

Although it’s known that women with autoimmune conditions are at increased risk of adverse birth outcomes, less understood is the role played by pregnancy complications on adverse birth outcomes in these women.

Dr. Bandoli photo

Dr. Bandoli

“Researchers and clinicians have suspected that part of the increased risk of adverse birth outcomes observed in women with autoimmune conditions may be mediated through adverse pregnancy outcomes,” says the study’s lead author, Gretchen Bandoli, PhD, assistant adjunct professor, Department of Pediatrics and Department of Family Medicine and Public Health, University of California, San Diego.

A Look at the Study

The study set out to better understand the direct (i.e., non-mediated) and indirect (i.e., mediated) effects of select autoimmune conditions on adverse pregnancy outcomes. It expands on previous data, which showed that women with RA, SLE and psoriasis have a 1.5- to 2.0-fold increased risk of preterm birth and cesarean delivery by quantifying the proportion of that excess risk attributable to pregnancy complications.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The investigators used a causal mediation analysis to estimate the total effects of each of four autoimmune conditions—RA, SLE, psoriasis and inflammatory bowel disease (IBD)—on adverse pregnancy outcome, as well as the indirect effects due to pregnancy complications.

“In brief, mediation occurs when an exposure causes an event, which in turn causes the outcome of interest,” says Dr. Bandoli. A causal mediation analysis, she explains, “allows for interactions between the exposure and mediators, and is robust to confounding that may bias traditional mediation analyses.”

The study population was drawn from a cohort of women with live-born singletons born between 20 and 44 weeks of gestation in California between 2007 and 2012, and further restricted to mother-infant dyads with linked hospital discharge records (n=2,963,888). Of that population, 3,129 (0.11%) were women with RA, 3,863 (0.13%) with SLE, 1,255 (0.04%) with psoriasis and 2,714 (0.09%) with IBD. Birth outcomes examined included preterm birth, cesarean delivery and small-for-gestational-
age offspring. Pregnancy complications (potential mediators) studied included preeclampsia, gestational diabetes and infections. Table 1 lists the key findings of the study.

ConditionResults
RA• Twofold increased risk of preterm birth compared to women without RA.
• Preeclampsia/hypertension accounted for 20% of excess preterm birth, pregnancy infection for 7% and gestational diabetes for 2%.
• Preeclampsia/hypertension accounted for 13% of excess cesarean delivery and 8% of small-for-gestational-age offspring.
SLE• Threefold increased risk of preterm birth and nearly twofold increased risk of small-for-gestational-age offspring compared with women without SLE.
• Preeclampsia/hypertension accounted for 18–30% excess adverse birth outcomes.
• Pregnancy infection accounted for 7% of excess preterm births.
• Gestational diabetes contributed no excess risk to any adverse birth outcomes.
Psoriasis• Preeclampsia accounted for 33% of excess preterm births and 12% of excess cesarean deliveries.
• Gestational diabetes and pregnancy infections accounted for 9% of excess preterm births.
IBD• Total risks for adverse birth outcomes are similar to those in women with RA.
• Pregnancy complications mediated <10% of excess risk of any adverse birth outcome.
ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Overall, preeclampsia proved to be the most important mediator of excess birth outcomes risk in select women. The study found women with RA, SLE and psoriasis had a 20–30% excess risk of preterm births and a 10–20% excess risk of cesarean delivery, mediated by preeclampsia. Although women with IBD had the same increased risk of preterm birth and cesarean delivery as women with RA, preeclampsia was not found to mediate the excess risk.

Other pregnancy complications played less of a mediating role in excess adverse birth outcomes. Gestational diabetes and pregnancy infections accounted for less than 10% of excess risk of preterm birth, cesarean delivery or small-for-gestational-age offspring regardless of the type of autoimmune condition.

Using the same model, the investigators stratified the population by race/ethnicity (i.e., non-Hispanic white, Latina, Black and Asian women) to see if mediation differed by race/ethnicity. Table 2 highlights key findings of that analysis.

ConditionResults
RA• Preterm births were highest in Black women.
• Risk of cesarean delivery was highest in Latinas.
• Risk of small-for-gestational-age offspring was highest in Asian women.
• Latinas had the highest proportion of excess preterm births (25.6%) attributable to preeclampsia/hypertension and pregnancy infection (9%).
• Black women had the highest proportion of excess preterm births attributed to gestational diabetes (6.8%).
SLE• Latinas (34.7%) and Asian women (36.4%) had the highest proportion of excess preterm births mediated by preeclampsia/hypertension.
• White women (19.5%) had the lowest proportion of excess preterm births mediated by preeclampsia/hypertension.
Psoriasis• Little heterogeneity was found in total effect estimates by race/ethnicity on preterm birth or risk of cesarean delivery or on the proportion mediated by pregnancy complications.
• Preeclampsia attributed to preterm birth was highest among Latinas (<10%).
• Impact of IBD on preterm births was strongest among Black women.

Dr. Bandoli says further heterogeneity was found when assessing mediated pathways by race/ethnicity, although the patterns differed when examining the different autoimmune conditions. She underscores that sample sizes were limited when the analysis was narrowed by race/ethnicity and disease.

“Overall, we found Latinas with RA and Latinas and Asian women with SLE may benefit the most from interventions targeting preeclampsia/hypertension with respect to the increased risk of preterm birth,” she says.

Pages: 1 2 | Single Page

Filed Under: Conditions, Research Reviews Tagged With: preeclampsia, pregnancyIssue: December 2020

You Might Also Like:
  • Lupus Flares Pose Greatest Risk for Adverse Pregnancy Outcomes in Women with SLE
  • A More Complicated Pregnancy: Inflammatory Arthritis Increases the Risk for Adverse Outcomes
  • Juvenile-Onset Arthritis Bodes Worse Pregnancy Outcomes
  • Antiphospholipid Antibody Syndrome Puts Pregnant Women at High Risk of Preeclampsia

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.